Total Payments
$11,285
2024 Payments
$381.13
Companies
39
Transactions
225
Medicare Patients
15,713
Medicare Billing
$6.2M
Payment Breakdown by Category
Food & Beverage$5,575 (49.4%)
Consulting$5,300 (47.0%)
Travel$201.38 (1.8%)
Research$187.21 (1.7%)
Education$20.88 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,575 | 219 | 49.4% |
| Consulting Fee | $5,300 | 1 | 47.0% |
| Travel and Lodging | $201.38 | 2 | 1.8% |
| Unspecified | $187.21 | 1 | 1.7% |
| Education | $20.88 | 2 | 0.2% |
Payments by Type
General
$11,098
224 transactions
Research
$187.21
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $5,482 | 3 | $0 (2021) |
| Medtronic, Inc. | $1,215 | 17 | $0 (2024) |
| Medtronic Vascular, Inc. | $903.99 | 17 | $0 (2020) |
| Amgen Inc. | $595.92 | 43 | $0 (2022) |
| Abbott Laboratories | $390.87 | 8 | $0 (2022) |
| Cardiovascular Systems Inc. | $357.45 | 18 | $0 (2023) |
| Gilead Sciences, Inc. | $255.74 | 18 | $0 (2019) |
| Ra Medical Systems, Inc. | $204.44 | 21 | $0 (2019) |
| Boston Scientific Corporation | $203.52 | 8 | $0 (2024) |
| Eli Lilly and Company | $187.21 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $381.13 | 10 | Eli Lilly and Company ($187.21) |
| 2023 | $816.17 | 16 | Medtronic, Inc. ($438.04) |
| 2022 | $426.04 | 22 | Cardiovascular Systems Inc. ($87.17) |
| 2021 | $6,393 | 24 | AngioDynamics, Inc. ($5,466) |
| 2020 | $161.68 | 7 | Edwards Lifesciences Corporation ($49.60) |
| 2019 | $677.71 | 46 | Ra Medical Systems, Inc. ($164.75) |
| 2018 | $1,434 | 47 | Medtronic Vascular, Inc. ($738.18) |
| 2017 | $994.17 | 53 | Amgen Inc. ($371.93) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | Eli Lilly and Company | — | — | In-kind items and services | $187.21 | Research |
| Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE | ||||||
| 10/03/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Not Applicable | ||||||
| 07/19/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Varithena_PI | ||||||
| 07/19/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Varithena_PI | ||||||
| 07/02/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Not Applicable | ||||||
| 06/26/2024 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $36.67 | General |
| Category: EndoVenous Therapies | ||||||
| 05/08/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 04/01/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Not Applicable | ||||||
| 12/19/2023 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $93.96 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 11/30/2023 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Vascular/Oncology | ||||||
| 11/29/2023 | Becton, Dickinson and Company | RotarexS 6 F x 135 cm (Device) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Vascular/Oncology | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $90.77 | General |
| 10/30/2023 | Bard Peripheral Vascular, Inc. | LUTONIX Drug Coated Balloon (Device) | Food and Beverage | In-kind items and services | $134.44 | General |
| Category: Vascular/Oncology | ||||||
| 10/29/2023 | Medtronic, Inc. | — | Food and Beverage | In-kind items and services | $78.46 | General |
| 10/28/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $166.96 | General |
| Category: EndoVenous Therapies | ||||||
| 09/20/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/05/2023 | Surmodics, Inc. | Pounce Thrombectomy System (Device), Pounce Venous Thrombectomy System, Sublime 014 Rx PTA Balloon Dilatation Catheter | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Percutaneous Catheter System | ||||||
| 08/09/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/26/2023 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Other Advanced Wound Management | ||||||
| 07/19/2023 | Medtronic, Inc. | VENASEAL (Device) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: EndoVenous Therapies | ||||||
| 05/16/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $34.83 | General |
| Category: Spinal Cord Stimulator | ||||||
| 04/13/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE | Eli Lilly and Company | $187.21 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,730 | 7,010 | $7.2M | $1.7M |
| 2022 | 26 | 5,040 | 8,435 | $7.0M | $1.8M |
| 2021 | 27 | 3,506 | 5,854 | $7.1M | $1.8M |
| 2020 | 32 | 3,437 | 5,695 | $4.2M | $1.0M |
Total Patients
15,713
Total Services
26,994
Medicare Billing
$6.2M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 236 | 571 | $3.0M | $652,180 | 22.0% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 183 | 304 | $2.1M | $443,390 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,507 | 3,877 | $1.1M | $401,623 | 37.7% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 72 | 91 | $545,545 | $82,507 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 474 | 659 | $115,325 | $44,728 | 38.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 39 | 40 | $63,400 | $14,637 | 23.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 140 | 150 | $27,750 | $10,558 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 67 | 67 | $25,125 | $9,099 | 36.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 39 | 160 | $27,800 | $7,544 | 27.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 505 | 567 | $104,895 | $6,525 | 6.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 96 | 106 | $15,900 | $4,775 | 30.0% |
| 78431 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | Office | 2023 | 55 | 55 | $15,675 | $3,997 | 25.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 34 | 36 | $12,600 | $3,645 | 28.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 24 | 24 | $14,040 | $3,608 | 25.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 55 | 56 | $27,160 | $2,968 | 10.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $8,800 | $2,923 | 33.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 39 | 80 | $47,600 | $2,831 | 5.9% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 12 | $8,220 | $1,512 | 18.4% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 55 | 55 | $6,875 | $1,327 | 19.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 17 | $4,845 | $1,029 | 21.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 51 | 51 | $3,825 | $586.50 | 15.3% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2022 | 188 | 448 | $2.3M | $536,029 | 23.0% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2022 | 162 | 260 | $1.8M | $395,900 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,376 | 3,233 | $889,075 | $341,707 | 38.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 899 | 1,727 | $302,225 | $130,273 | 43.1% |
About Dr. Vinod Kumar, M.D
Dr. Vinod Kumar, M.D is a Interventional Cardiology healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730142993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vinod Kumar, M.D has received a total of $11,285 in payments from pharmaceutical and medical device companies, with $381.13 received in 2024. These payments were reported across 225 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,575).
As a Medicare-enrolled provider, Kumar has provided services to 15,713 Medicare beneficiaries, totaling 26,994 services with total Medicare billing of $6.2M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Nuclear Cardiology, Cardiovascular Invasive Specialist
- Location Bakersfield, CA
- Active Since 04/10/2006
- Last Updated 05/15/2024
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1730142993
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $5,466
- Ellipsys (Device) $568.23
- ClosureFast (Device) $538.90
- Repatha (Biological) $323.52
- Corlanor (Drug) $265.41
- Peripheral Orbital Atherectomy System (Device) $230.30
- VENASEAL (Device) $211.52
- DABRA (Device) $164.75
- IN.PACT Admiral (Device) $153.41
- Valiant Captivia (Device) $149.95
- Perclose ProGlide suture mediated closure system (Device) $149.45
- StarClose SE vascular closure system (Device) $137.44
- LUTONIX Drug Coated Balloon (Device) $134.44
- Diamondback Peripheral (Device) $127.15
- VenaSeal (Device) $113.70
- Livalo (Drug) $110.18
- NEXLETOL (Drug) $108.82
- GENERAL THERAPIES (Device) $102.66
- ZIO Patch (Device) $94.49
- ACCURIAN (Device) $93.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Bakersfield
Rasham Deep Sandhu, M.d, M.D
Interventional Cardiology — Payments: $68,550
Interventional Cardiology $68,550
Atul Aggarwal, Md, MD
Interventional Cardiology — Payments: $20,029
Interventional Cardiology $20,029
Nirav Desai, M.d, M.D
Interventional Cardiology — Payments: $6,278
Interventional Cardiology $6,278
Jonah Lahip, Np, NP
Interventional Cardiology — Payments: $2,611
Interventional Cardiology $2,611
Dr. Chun Yueh Wen, M.d, M.D
Interventional Cardiology — Payments: $53.27
Interventional Cardiology $53.27